RESUMEN

Stereotactic body radiation therapy is the standard treatment for inoperable patients with early-stage lung cancer. Local control rates range from 80 to 90 % 2 years after treatment. The role of positron emission tomography in patient selection is well known, but its use for target definition or therapeutic response evaluation is less clear. We reviewed the literature in order to assess the current state of knowledge in this area.

Asunto(s)

Neoplasias Pulmonares/diagnóstico por imagen , Neoplasias Pulmonares/cirugía , Tomografía de Emisión de Positrones , Radiocirugia , Fluorodesoxiglucosa F18 , Humanos , Planificación de Atención al Paciente , Radiofármacos